Katelyn Daman (University of Massachusetts) used DUX4-targeting siRNAs formulated with docosanoic acid to facilitate delivery to FSHD myoblasts, FSHD myotubes, and an FSHD xenograft model. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.